It is a chemicals private limited company based in Thane, Maharashtra, India, established in 2015.
2015 | Thane, Maharashtra, India | ActiveKapstone India Pharmaceuticals Private Limited, a active private limited company, was established on 30 June 2015 in Thane, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233MH2015PTC266129. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sunita Ramrao Kendre (Director), Ankush Kendre Ramrao (Director), Lav Kendre Ramrao (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Plot No. A-337 & A-339, Road No. 25, Village Panchpakhadi, Wagle Industrial E, State,, Thane, Maharashtra, 400604.
U24233MH2015PTC266129
266129
30 June 2015
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kapstone India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunita Ramrao Kendre | Director | 30 Jun 2015 | Current |
| Ankush Kendre Ramrao | Director | 30 Jun 2015 | Current |
| Lav Kendre Ramrao | Director | 30 Jun 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kapstone India Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 408.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2017, Kapstone India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kapstone India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kapstone India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kapstone India Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kapstone India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on Kapstone India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.
The activity Sunita Ramrao Kendre was appointed as a Director was appointed as a Director on 30 Jun 2015 & has been associated with this company since 10 years 5 months . was completed.
Progress on Ankush Kendre Ramrao was appointed as a Director was appointed as a Director on 30 Jun 2015 & has been associated with this company since 10 years 5 months . was documented.
The activity Lav Kendre Ramrao was appointed as a Director was appointed as a Director on 30 Jun 2015 & has been associated with this company since 10 years 5 months . was completed.
The activity Kapstone India Pharmaceuticals Private Limited was registered on 30 Jun 2015 with Roc Mumbai & aged 10 years 5 months as per MCA records. was completed.
The CIN of Kapstone India Pharmaceuticals Private Limited is U24233MH2015PTC266129.
Kapstone India Pharmaceuticals Private Limited is headquartered at Plot No. A-337 & A-339, Road No. 25, Village Panchpakhadi, Wagle Industrial E, State,, Thane, Maharashtra, 400604.
Kapstone India Pharmaceuticals Private Limited was incorporated on 30 June 2015.
The current directors of Kapstone India Pharmaceuticals Private Limited are
The primary industry of Kapstone India Pharmaceuticals Private Limited is Chemicals.
Kapstone India Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kapstone India Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Kapstone India Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX